We are live on ! Find out more
GLRA

Gerald L. Ray & Associates Portfolio holdings

AUM $802M
1-Year Est. Return 21.01%
This Fund
S&P 500
This Quarter Est. Return
+3.98%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$802M
AUM Growth
+$26.7M
Cap. Flow
+$2.39M
Cap. Flow %
0.3%
Top 10 Hldgs %
28.66%
Holding
337
New
15
Increased
53
Reduced
138
Closed
9

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$9.04M
2
CLVS
Clovis Oncology, Inc.
CLVS
+$3.38M
3
AMD icon
Advanced Micro Devices
AMD
+$2M
4
TECD
Tech Data Corp
TECD
+$1.52M
5
QCOM icon
Qualcomm
QCOM
+$618K

Top Sells

Rank Stock Value
1
DD
Du Pont De Nemours E I
DD
+$8.72M
2
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$1.76M
3
TWLO icon
Twilio
TWLO
+$731K
4
UAA icon
Under Armour
UAA
+$709K
5
LUV icon
Southwest Airlines
LUV
+$684K

Sector Composition

Rank Sector Weight
1 Healthcare 22.98%
2 Industrials 15.02%
3 Technology 10.52%
4 Financials 9.61%
5 Consumer Staples 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLF icon
201
State Street Financial Select Sector SPDR ETF
XLF
$55.4B
$661K 0.08%
25,574
– –
LAD icon
202
Lithia Motors
LAD
$7.54B
$650K 0.08%
5,400
– –
UPS icon
203
United Parcel Service
UPS
$96.2B
$650K 0.08%
5,416
– –
ACC
204
DELISTED
American Campus Communities, Inc.
ACC
$649K 0.08%
14,700
– –
IFLN
205
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$307M
$646K 0.08%
33,850
– –
BAX icon
206
Baxter International
BAX
$11.4B
$634K 0.08%
10,100
– –
FNDF icon
207
Schwab Fundamental International Large Company Index ETF
FNDF
$24.4B
$633K 0.08%
21,200
– –
ALB icon
208
Albemarle
ALB
$14B
$630K 0.08%
4,625
– –
AVGO icon
209
Broadcom
AVGO
$1.84T
$623K 0.08%
25,700
+8,100
+46% +$200K
VTI icon
210
Vanguard Total Stock Market ETF
VTI
$662B
$609K 0.08%
4,700
+830
+21% +$105K
DON icon
211
WisdomTree US MidCap Dividend Fund
DON
$4.01B
$600K 0.07%
18,000
– –
HOLX
212
DELISTED
Hologic
HOLX
$600K 0.07%
16,350
– –
VNO icon
213
Vornado Realty Trust
VNO
$7.48B
$592K 0.07%
7,700
-1,825
-19% -$139K
ORCL icon
214
Oracle
ORCL
$366B
$591K 0.07%
12,216
– –
DHR icon
215
Danaher
DHR
$127B
$590K 0.07%
7,761
– –
HACK icon
216
Amplify Cybersecurity ETF
HACK
$2.7B
$578K 0.07%
19,210
+500
+3% +$14.9K
IHE icon
217
iShares US Pharmaceuticals ETF
IHE
$1.45B
$574K 0.07%
11,007
+3,240
+42% +$166K
DXCM icon
218
DexCom
DXCM
$29.2B
$552K 0.07%
45,100
+500
+1% +$8.84K
SNY icon
219
Sanofi
SNY
$105B
$550K 0.07%
11,042
-300
-3% -$14.5K
CTXS
220
DELISTED
Citrix Systems Inc
CTXS
$547K 0.07%
7,125
– –
SOXX icon
221
iShares Semiconductor ETF
SOXX
$46.3B
$545K 0.07%
10,305
– –
DGS icon
222
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.72B
$532K 0.07%
10,852
-5
-0% -$241
SCHM icon
223
Schwab US Mid-Cap ETF
SCHM
$14.7B
$530K 0.07%
+31,725
New +$516K
DAL icon
224
Delta Air Lines
DAL
$55.7B
$527K 0.07%
10,925
-96
-0.9% -$4.79K
STLA icon
225
Stellantis
STLA
$16.7B
$527K 0.07%
29,400
-118
-0.4% -$1.63K
7 8
9
10 11

Similar funds

KRC
Kingdom Ridge Capital White Plains, New York $750M AUM 34.23% 1-Year Est. Return
GS
GAM Systematic Cambridge, United Kingdom $696M AUM 28.4% 1-Year Est. Return
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO) Irvine, California $913M AUM 18.29% 1-Year Est. Return
B
BancorpSouth Tupelo, Mississippi $1.01B AUM 4.88% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return
NBC
Neuberger Berman Canada Toronto, Ontario, Canada $542M AUM 14.17% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
SD
Sumway Development Shanghai, China $427M AUM 43.82% 1-Year Est. Return

Gerald L. Ray & Associates's Q3 2017 Portfolio in Review

As of Q3 2017, Gerald L. Ray & Associates held 337 positions worth $802M, up 3.4% from $775M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Gerald L. Ray & Associates's Q3 2017 filing shows 15 new, 53 increased, 138 reduced and 9 closed positions. Its largest new stake was Clovis Oncology, Inc.: 42,630 shares worth $3.51M. The largest sale was Du Pont De Nemours E I, an estimated $8.72M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Industrials and Technology.

  • Gerald L. Ray & Associates's largest Q3 2017 buy was Clovis Oncology, Inc.: 42,630 shares worth $3.51M.
  • Gerald L. Ray & Associates added most to DuPont de Nemours in Q3 2017, an estimated $9.04M increase.
  • Gerald L. Ray & Associates's biggest Q3 2017 reduction was Under Armour, cutting an estimated $709K.
  • Gerald L. Ray & Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $8.72M.
  • Gerald L. Ray & Associates's ten largest holdings make up 29% of its $802M portfolio in Q3 2017.
  • Gerald L. Ray & Associates opened 15 new positions and closed 9 in Q3 2017.
  • Gerald L. Ray & Associates's portfolio value rose 3.4% quarter-over-quarter to $802M.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2017, filed 31 Oct 2017.